Retinalamin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRetinalamin
Drug Alias NameRetilinRetinalamin
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract > Animal extract
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetic RetinopathyGlaucoma, Open-AngleRetinal Dysplasia
Global Approved IndicationsDiabetic RetinopathyGlaucoma, Open-AngleRetinal Dysplasia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2008/01/01
Country/TerritoryArmeniaUkraineUzbekistan +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGeropharm
China Registration ClassN/A

Develop Information

Active CompaniesGeropharm
Inactive CompaniesN/A
Active IndicationsDiabetic RetinopathyGlaucoma, Open-AngleRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeL03A
Related LinksN/A